LataMed AI is trading at $0.04, down 7.7%, with no catalyst established by the available evidence. - No clear company-specific announcement or event dated November 3, 2026, surfaced; the latest listed company releases in the search results are from September. - The broader market was mixed, with the Nasdaq higher and the Dow lower, offering no clear explanation for the decline. - Live-session trading volume was not available in the provided price context.